PubMed:24403068 / 0-121
Annnotations
sentences
{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":107},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it "}
DisGeNET
{"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":0,"end":22},"obj":"gene:5552"},{"id":"T1","span":{"begin":39,"end":55},"obj":"disease:C0026764"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it "}
DisGeNET5_gene_disease
{"project":"DisGeNET5_gene_disease","denotations":[{"id":"24403068-0#0#22#gene5552","span":{"begin":0,"end":22},"obj":"gene5552"},{"id":"24403068-0#39#55#diseaseC0026764","span":{"begin":39,"end":55},"obj":"diseaseC0026764"}],"relations":[{"id":"0#22#gene555239#55#diseaseC0026764","pred":"associated_with","subj":"24403068-0#0#22#gene5552","obj":"24403068-0#39#55#diseaseC0026764"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it "}
mondo_disease
{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":39,"end":55},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it "}
GlyCosmos15-HP
{"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":39,"end":55},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0006775"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it "}
GlyCosmos15-MONDO
{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T1","span":{"begin":39,"end":55},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it "}
sentences
{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":107},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it "}
GlyCosmos15-Sentences
{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":107},"obj":"Sentence"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it "}
HP-phenotype
{"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":39,"end":55},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0006775"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.\nRecently, it "}